The healthcare community is intrigued by retatrutide, a novel dual GIP and GLP-1 agonist that’s showing impressive results in preliminary studies . This compound works by imitating natural hormones to affect appetite and promote feelings of satisfaction , ultimately resulting in noticeable weight loss . While presently under evaluation and not br